Trials / Completed
CompletedNCT00446771
A Pharmacokinetic and Bioavailability Study of Mannitol for Inhalation Using Normal Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 18 (planned)
- Sponsor
- Syntara · Industry
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The study has an open-label, randomized, crossover design, in which each subject will receive mannitol powder for inhalation using a dry powder inhaler with and without premedication with a bronchodilator, mannitol powder for inhalation in capsules administered orally, and mannitol in a commercial formulation designed for intravenous use.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Mannitol |
Timeline
- Start date
- 2006-10-01
- Completion
- 2006-11-01
- First posted
- 2007-03-13
- Last updated
- 2007-03-13
Source: ClinicalTrials.gov record NCT00446771. Inclusion in this directory is not an endorsement.